| Identification | Back Directory | [Name]
Vesicular Stomatitis Virus Nucleoprotein (52-59) | [CAS]
132326-74-0 | [Synonyms]
Vesicular Stomatitis Virus Nucleoprotein (52-59)
L-Leucine, L-arginylglycyl-L-tyrosyl-L-valyl-L-tyrosyl-L-glutaminylglycyl- | [Molecular Formula]
C44H66N12O12 | [MOL File]
132326-74-0.mol | [Molecular Weight]
955.07 |
| Hazard Information | Back Directory | [Uses]
H2-D b restricted epitopes VSV Nucleoprotein (52-59) is a 9-mer peptide derived from the nucleoprotein of Vesicular Stomatitis Virus (VSV). H2-D b restricted epitopes VSV Nucleoprotein (52-59) binds to MHC class I molecules and presents itself to CD8+ T cells, thereby activating cytotoxic T lymphocytes (CTLs), which can recognize and kill cells expressing the corresponding antigen. H2-D b restricted epitopes VSV Nucleoprotein (52-59) can be used in the development of CTL vaccines against Ebola virus[1]. | [References]
[1] Herst C V, et al. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design[J]. Vaccine, 2020, 38(28): 4464-4475. DOI:10.1016/j.vaccine.2020.04.034 |
|
| Company Name: |
Enzo Biochem Inc
|
| Tel: |
Enzo Biochem Inc. 13797054060 |
| Website: |
www.enzo.com |
|